معرفی
Daniele Zampieri is a Researcher in the Department of Pharmaceutical Sciences at the University of Trieste, where he holds a teaching assignment and serves as a member of the Department's Board and Boards of Studies. He also acts as an External Expert for Doctoral Studies Boards in Chemistry.
- PhD in Pharmaceutical Sciences, University of Trieste (2001)
- Graduate in Medicinal Chemistry and Technology, University of Trieste (1996)
- Master in Drug Development and Design, University of Pavia (2004)
Zampieri is an expert in the design and organic synthesis of small molecules with diverse therapeutic applications. His research initially focused on antimycobacterial and antifungal derivatives, then expanded to include neuroprotective compounds such as sigma ligands and GluN2b inhibitors through collaborations with the Universities of Pavia, Muenster, and Catania. His current research involves antifibrotic compounds in collaboration with Prof. Zacchigna of the ICGEB, with molecular modeling support from Prof. Sara Fortuna.
Analysis of his publication record reveals a consistent focus on medicinal chemistry approaches to drug discovery, particularly targeting infectious diseases. His work demonstrates expertise in heterocyclic chemistry, with emphasis on imidazole, pyrazole, oxadiazole, and indole derivatives. Zampieri's research integrates synthetic chemistry with computational methods for drug design and structure-activity relationship studies.
Zampieri is an active member of the Mamolo and Zampieri Research Group, which focuses on two main research strands: the design and synthesis of new sigma ligands for biological evaluation, and the design and synthesis of novel antimycobacterial molecules. His work contributes significantly to the Drug Design, Synthesis and Formulation research area within the department.
